Zobrazeno 1 - 10
of 22
pro vyhledávání: '"C G Hanratty"'
Autor:
Lana J. Dixon, G. Dennis Johnston, Lawrence T. McGrath, Naglaa A. El-Sherbeeny, Paul Hamilton, William J. Leahey, C G Hanratty, David R. Morgan, Gary E. McVeigh
Publikováno v:
The American Journal of Cardiology. 97:547-551
We investigated the effects of omega-3 fatty acids administration on endothelium-dependent vasodilation in patients > or =65 years old who received treatment for chronic heart failure (CHF). Twenty patients (mean age 73 years; 15 men) with grade II a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36bd646f83eb8180d5b803e0e7911816
https://doi.org/10.1016/j.amjcard.2005.08.075
https://doi.org/10.1016/j.amjcard.2005.08.075
Autor:
Ronan Donnelly, Michael P. Frenneaux, M Riley, C O'Dochartaigh, Hean Ong, Ian S. Young, C G Hanratty, S. L. Lovell, Paul Nicholls
Publikováno v:
Clinical Science. 106:413-419
Elevated blood levels of Hcy (homocysteine) are associated with endothelial dysfunction in the systemic and coronary arterial beds. We wished to know if similar changes could be detected in the pulmonary circulation, using non-invasive tests. We stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a56aee21a6b983c999671d1876131085
https://doi.org/10.1042/cs20030383
https://doi.org/10.1042/cs20030383
Autor:
Gary E. McVeigh, Bernard Silke, Lana J. Dixon, C G Hanratty, Douglas R. Morgan, Patrick Allen
Publikováno v:
European Journal of Clinical Pharmacology. 59:195-199
To evaluate the effects of the intravenous administration of the nitric oxide synthesis inhibitor N(g)nitro-L-arginine methyl ester (L-NAME) in healthy volunteers.L-NAME (0.25, 0.5 and 0.75 mg/kg over 8 min) was infused in 13 healthy male volunteers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcc9ad78734238c8040d21d846c7f9b1
https://doi.org/10.1007/s00228-003-0601-7
https://doi.org/10.1007/s00228-003-0601-7
Autor:
Adrian Devine, C G Hanratty, Lawrence T. McGrath, David G.A. Morgan, Lana J. Dixon, Martin Wilson, Gary E. McVeigh, Paul Hamilton, William J. Leahey
Publikováno v:
Circulation. 106:208-213
Background — The therapeutic benefits that accompany the continuous administration of organic nitrates are attenuated by the development of tolerance to the compounds. Altered superoxide production and NO bioavailability have been implicated in con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa1e9e64970e405195a4d9f5383227c3
https://doi.org/10.1161/01.cir.0000021600.84149.78
https://doi.org/10.1161/01.cir.0000021600.84149.78
Publikováno v:
Europace. 4:281-287
The embryological development of the superior vena cava (SVC) is complex. If the left common cardinal vein fails to occlude it can, along with the left duct of Cuvier form a left SVC, which frequently drains into the coronary sinus. This may result i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ada1990a336acade28e8263e7dd19074
https://doi.org/10.1053/eupc.2002.0248
https://doi.org/10.1053/eupc.2002.0248
Publikováno v:
Heart. 85:326-330
BACKGROUND—Raised homocysteine is a risk factor for vascular disease. Homocysteine is formed from methionine, and dietary manipulation of homocysteine in primates and humans with oral methionine is associated with endothelial dysfunction. A cause-e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2d92980b460269abaf03336387ae002
https://doi.org/10.1136/heart.85.3.326
https://doi.org/10.1136/heart.85.3.326
Vasoconstriction to Endothelin-1 is Blunted in Non-Insulin-Dependent Diabetes: A Dose-Response Study
Publikováno v:
Journal of Cardiovascular Pharmacology. 36:203-208
The haemodynamic hypothesis for the pathogenesis of diabetic microangiopathy argues that an initial increase in microvascular blood flow leads to microvascular sclerosis and disturbed autoregulation. Endothelin-1 (ET-1) is an endothelium-derived vaso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::598d42b508e67a8abb866ae0f0259ce6
https://doi.org/10.1097/00005344-200008000-00010
https://doi.org/10.1097/00005344-200008000-00010
Publikováno v:
Journal of Cardiovascular Pharmacology. 33:859-867
Full antagonists of the cardiac beta-adrenoceptor improve heart-rate variability (HRV) in humans; however, partial agonism at the beta2-adrenoceptor has been suggested to decrease HRV. We therefore studied the HRV effects of some partial agonists of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9baf94f8a7aabc9f3a417e6843940d6
https://doi.org/10.1097/00005344-199906000-00005
https://doi.org/10.1097/00005344-199906000-00005
Publikováno v:
British Journal of Clinical Pharmacology. 47:157-166
AIMS To examine the impact on heart rate variability (HRV), of agonism or antagonism at the cardiac beta2-adrenoceptor in healthy volunteers, using standard time-domain summary statistics and non-linear methods (scatterplot and quadrant analysis). ME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eaf650f40745731933197f50a704828
https://doi.org/10.1046/j.1365-2125.1999.00862.x
https://doi.org/10.1046/j.1365-2125.1999.00862.x
Publikováno v:
Coronary Artery Disease. 10:633-640
Left ventricular hypertrophy (LVH) is an important independent risk factor for cardiovascular disease and is associated with an increased risk of ventricular dysrhythmia, coronary artery disease, myocardial infarction, stroke, heart failure and perip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d791e6e217406c3267156312dbd4cc7
https://doi.org/10.1097/00019501-199912000-00013
https://doi.org/10.1097/00019501-199912000-00013